| Metric | This Period | Prior Year | YoY |
|---|---|---|---|
| Revenue / Net Sales | ¥65.7B | ¥61.0B | +7.8% |
| Operating Income / Operating Profit | ¥13.2B | ¥12.5B | +5.3% |
| Ordinary Income | ¥12.4B | ¥14.0B | -11.3% |
| Net Income / Net Profit | ¥8.0B | ¥8.4B | -3.9% |
| ROE | 18.4% | 18.3% | - |
FY2026 Full Year results landed at Revenue ¥65.7B (YoY +¥4.8B +7.8%), Operating Income ¥13.2B (YoY +¥0.7B +5.3%), Ordinary Income ¥12.4B (YoY -¥1.6B -11.3%), Net Income ¥8.0B (YoY -¥0.3B -3.9%). Core business achieved revenue and operating profit growth, with gross margin improving to 83.2% (prior 80.9%) +230bp, but SG&A of ¥41.5B (YoY +¥4.7B +12.7%) grew faster than revenue, negating operating leverage and shrinking operating margin to 20.1% (prior 20.6%) -50bp. At the ordinary level, an increase in non-operating expenses to ¥1.0B (prior ¥0.3B) and a decrease in non-operating income to ¥0.2B (prior ¥1.7B) led to profit decline. Net income margin fell about 150bp to 12.2% (prior 13.7%), though ROE remained high at 18.4%. By segment, the EC Business led with Revenue ¥39.0B (+9.5%) and Operating Income ¥12.7B (+2.7%), while the Financial Business contributed with Revenue ¥30.4B (+6.2%) and Operating Income ¥8.3B (+13.5%). Overall, the company delivered revenue and operating profit growth but saw declines at the ordinary and net levels due to deterioration in non-operating items.
[Revenue] Topline expanded steadily to ¥65.7B, up +7.8% YoY. The EC Business at ¥39.0B (share 59.3%, +9.5%) drove growth, and the Financial Business at ¥30.4B (share 46.2%, +6.2%) also grew smoothly. Gross margin improved +230bp to 83.2%, compressing cost of goods sold ratio to 16.8%. Improvement in price mix and optimization of service composition supported gross margin expansion.
[Profitability] Operating Income was ¥13.2B (+5.3%), but the pace of SG&A increase (+12.7%) outpaced revenue growth, reversing operating leverage. SG&A ratio rose to 63.1% (prior 60.4%) +270bp, and operating margin narrowed to 20.1% (prior 20.6%) -50bp. Ordinary Income fell sharply to ¥12.4B (-11.3%), as non-operating expenses increased to ¥1.0B (prior ¥0.3B) including interest expense ¥0.1B and investment partnership operating loss ¥0.6B. Non-operating income decreased to ¥0.2B (prior ¥1.7B) reflecting the drop-off in investment partnership gains. After recording special losses of ¥1.5B (same level as prior year) and tax expense of ¥4.4B (effective tax rate 35.1%), Net Income reached ¥8.0B (-3.9%). Net income margin declined by ~150bp to 12.2%. In summary, despite revenue and operating profit growth, higher SG&A and expanded non-operating expenses produced lower ordinary and net profits — a revenue-up, profit-down result.
The EC Business finished at Revenue ¥39.0B (+9.5%), Operating Income ¥12.7B (+2.7%), with a margin of 32.6%. Margin declined 220bp from prior Operating Income ¥12.4B (margin 34.8%) as SG&A rose ahead of sales growth. The Financial Business recorded Revenue ¥30.4B (+6.2%), Operating Income ¥8.3B (+13.5%), margin 27.4%. Operating Income improved from prior ¥7.3B (margin 25.7%), reflecting realized scale benefits. The EC Business remains the core contributor to revenue and operating income, while the Financial Business’s profit growth serves as a growth balancer for the company.
[Profitability] Operating margin 20.1% (prior 20.6%) contracted 50bp due to SG&A increases, while gross margin remained high at 83.2% (+230bp). Net income margin 12.2% (prior 13.7%) fell 150bp due to deterioration in non-operating results. ROE 18.4% (prior 18.2%) remained high as increased leverage offset declines in margin and turnover. DuPont decomposition is comprised of Net Income Margin 12.2% × Total Asset Turnover 0.339 × Financial Leverage 4.43, versus prior (Net Income Margin 13.7%, Turnover 0.376, Leverage 3.54) — reflecting -150bp margin, -0.037 turnover, and +0.89pt leverage. [Cash Quality] Operating Cash Flow / Net Income is 0.86x — minimally acceptable — but OCF/EBITDA (Operating Income + Depreciation) is weak at 0.47x, with Accounts Receivable increase of ¥18.5B pressuring working capital. [Investment Efficiency] Total Asset Turnover declined to 0.339x (prior 0.376x) as total assets grew +19.6% despite sales growth of +7.8%. Accounts Receivable ¥107.0B (≈163% of sales) is the main driver of asset expansion. [Financial Health] Equity Ratio 22.6% (prior 28.3%) declined -570bp; D/E ratio 3.43x (prior 2.54x) indicates higher leverage. Current Ratio improved to 134.6% (prior 124.5%), but non-current liabilities ¥28.9B (+207%) rose mainly due to recognition of convertible bonds ¥20B, shifting the capital structure toward liabilities.
Operating Cash Flow was ¥6.9B (prior ¥10.5B, -34.0%), with working capital movements detracting from pre-tax profit ¥12.4B. Accounts Receivable increase ¥18.5B absorbed cash, partially offset by Accounts Payable increase ¥17.2B. Corporate tax payments rose to ¥5.9B from ¥2.6B, compressing operating CF from a subtotal ¥12.9B to final ¥6.9B. Operating CF / Net Income 0.86x is minimally acceptable, but OCF/EBITDA 0.47x indicates weak cash conversion. Investing CF was -¥3.0B with minor CapEx ¥0.1B, investment securities acquisitions ¥1.2B, and intangible asset acquisitions ¥1.9B. Financing CF was +¥5.2B supported by funds raised from convertible bond issuance, while dividend payments ¥4.7B and share buybacks ¥6.5B were outflows. Free Cash Flow was ¥3.9B, insufficient to cover total shareholder returns ¥11.2B (dividends ¥4.7B + buybacks ¥6.5B), leaving financing CF to fill the gap. Cash increased by ¥9.1B to year-end cash ¥52.5B. Improving cash quality requires working capital optimization, with accelerated collections of accounts receivable the top priority.
Earnings quality is business-led and sound, but this period saw non-operating deterioration amplify noise at the ordinary level. Non-operating expenses ¥1.0B include interest expense ¥0.1B, bond issuance costs ¥0.1B, and investment partnership operating loss ¥0.6B; volatility in investment equity results is the primary cause of the -11.3% ordinary income decline. Non-operating income contracted to ¥0.2B from ¥1.7B prior. Special losses ¥1.5B were recorded at a similar scale as the prior year, so judgment on transience is cautious. The attenuation from Operating Income ¥13.2B → Ordinary Income ¥12.4B → Pre-tax Profit ¥12.4B → Net Income ¥8.0B is driven by non-operating items and tax burden, but there is no concern over business continuity. The accrual ratio ((Net Income - Operating CF) / Total Assets) is about 0.6%, low and indicating limited accounting-driven profit generation. However, OCF/EBITDA 0.47x reflects working capital strain from accounts receivable growth, so material room for cash-backed improvement remains. Non-operating income is less than 5% of sales, indicating high dependence on core business and generally recurring earnings quality, though attention is needed to volatility from investment-related gains/losses.
FY2027 Full Year forecast projects Revenue ¥75.0B (+14.1%), Operating Income ¥6.0B (-54.6%), Ordinary Income ¥5.5B (-55.6%), Net Income ¥3.0B (EPS ¥15.47). The company expects significant profit decline despite revenue growth. Operating margin is planned to fall to 8.0% (this period 20.1%) — a -1,210bp decline — likely reflecting front-loaded growth investment, strengthened promotion, normalization and build-up of credit costs, and changes in pricing and fee mix. The progress ratio versus current Operating Income is 6.0B ÷ 13.2B ≈ 45%, reflecting conservative assumptions. Dividend forecast DPS ¥11 (from ¥27 this period) implies a substantial cut, reducing payout ratio to about 71%. Achieving the plan requires containing SG&A growth and disciplined working capital management, making first-half progress monitoring important.
This period’s dividend was DPS ¥27 (interim ¥11 · year-end ¥16), with payout ratio about 71.4% (based on EPS ¥39.60), relatively high. This represented a large payout increase of +170% from prior DPS ¥10. Total dividends amounted to ¥4.7B, coverage versus FCF ¥3.9B was 0.83x, indicating insufficiency. Share buybacks of ¥6.5B were executed, bringing total shareholder returns to ¥11.2B, about 139% of Net Income ¥8.0B. Total return ratio is approximately 139%, which is excessive and raises sustainability concerns from a cash flow perspective. FY2027 DPS guidance is reduced to ¥11, suggesting normalization of payout and return levels. Cash and deposits ¥52.5B are ample, but given working capital pressure and rising leverage, future returns should reasonably revert to levels supported by FCF generation.
Accounts receivable increase and collection risk: Accounts Receivable ¥107.0B (+21.0%) equals about 163% of sales, keeping working capital strain elevated. Prolonged DSO or credit deterioration among counterparties could require increased allowance for doubtful accounts, impairing cash generation. Growth in the Financial Business could also raise credit cost levels that require monitoring.
High leverage and convertible bond risk: D/E ratio 3.43x is high, and recognition of Convertible Bonds ¥20B caused non-current liabilities to surge +207%. Conversion clause exercise could dilute equity; rising interest rates or refinancing needs could increase financial burden and constrain operational flexibility. Debt/EBITDA 0.77x suggests adequate debt-servicing capacity, but capital policy execution will be decisive for medium-to-long-term valuation.
Reverse operating leverage and next-year steep profit decline plan: SG&A growth (+12.7%) outpaced revenue growth (+7.8%), shrinking operating margin by 50bp. FY2027 plan foresees Operating Income ¥6.0B (-54.6%), driven by front-loaded growth investment, hiring, and rising credit costs. If SG&A remains fixed while price competition intensifies, profitability could deteriorate further and shareholder return capacity diminish.
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 20.1% | 8.1% (3.6%–16.0%) | +12.0pt |
| Net Income Margin | 12.2% | 5.8% (1.2%–11.6%) | +6.4pt |
Profitability substantially exceeds industry median, driven by a high gross margin and asset-light business model.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 7.8% | 10.1% (1.7%–20.2%) | -2.3pt |
Revenue growth is slightly below the industry median, suggesting relative deceleration versus high-growth peers.
※Source: Company aggregation
While core profitability remains high, working capital management and cash conversion are the top KPIs to improve. Accelerating collection of Accounts Receivable ¥107.0B (≈163% of sales) and reversing OCF/EBITDA 0.47x are prerequisites for sustaining dividends and investment capacity. Monitor credit cost trends as the Financial Business grows and optimize the accounts receivable/accounts payable balance.
Short-term focus is verification of the FY2027 steep profit decline plan (Operating Income -54.6%). Confirm assumptions on SG&A containment, timing of returns on growth investments, and realized credit costs in the first half. The dividend cut from DPS ¥27 → ¥11 signals normalization of total returns toward FCF coverage, which is healthy. Continue observing high leverage (D/E 3.43x), convertible bonds ¥20B dilution risk, and interest burden developments.
This report was automatically generated by AI analyzing XBRL earnings disclosure data. It does not constitute a recommendation to invest in any particular security. Industry benchmarks are reference information compiled by our firm based on public financial statements. Investment decisions should be made at your own discretion and, if necessary, after consulting a professional advisor.